Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Oncology, Cell Biology, 1109 Neurosciences, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, 3101 Biochemistry and cell biology, 3211 Oncology and carcinogenesis

Abstract:

© 2016 Elsevier Inc. (Cancer Cell 23, 489–501, April 15, 2013) In Figure 2F, the authors failed to highlight clearly that there is a split in the western blot (all rows) between the “0” and “0.1” condition. Even though all samples were run in the same experiment on the same blot, the image was split to remove samples that were simultaneously analyzed but irrelevant for this study. In the corrected Figure 2 F, the authors have now clearly separated both parts of the western blot. In Figure 5B, the image of the western blot showing total FGFR2 for the HEK293-FGFR2Y328D cell line was mistakenly replaced with the image of the western blot showing total FGFR2 for the HEK293-FGFR2WT cell line from Figure 5A. In the corrected Figure 5B, the authors have included the correct image of the western blot showing total FGFR2 for the HEK293-FGFR2Y328D cell line. The corrected Figure 2 and Figure 5 are included below. The authors apologize for any confusion these mistakes may have caused the readers.